Phenol

Description

Medpurine is presented in a container label format, detailing essential information regarding the product. The label includes specifications such as the chemical name, molecular weight, and structural formula, which are critical for identification and usage. Additionally, the label outlines the dosage form and appearance of the product, ensuring clarity for healthcare professionals. Inactive ingredients are also listed, providing comprehensive insight into the formulation. This information is crucial for proper handling, administration, and understanding of the product's characteristics.

Uses and Indications

This drug is indicated for the temporary relief of occasional minor throat irritation, pain, sore mouth, and sore throat.

There are no teratogenic or nonteratogenic effects mentioned associated with the use of this drug.

Dosage and Administration

Adults and children aged 3 years and older should apply one spray to the affected area. The spray must be allowed to remain in place for a minimum of 15 seconds before being expectorated. This product may be used every 2 hours or as directed by a healthcare professional. It is advised that children under 12 years of age be supervised during the application of this product.

For children under 3 years of age, consultation with a doctor or dentist is recommended prior to use.

Prior to the initial application, the protective neck band and dust cap must be removed from the tip of the bottle. To administer the spray, the bottle should be held upright, and the nozzle should be pressed down with the index finger without tilting the head. The pump should be fully depressed with a firm, even stroke, and the nozzle should be wiped dry after use.

Contraindications

There are no specific contraindications identified for this product. However, the following precautions should be observed:

• The recommended dose should not be exceeded to avoid potential adverse effects.

• The product should not be used for more than 2 days; it is intended for short-term use only as directed.

• To prevent the risk of infection, this product should not be used by more than one person.

Warnings and Precautions

Severe and persistent sore throat, particularly when accompanied by high fever, headache, nausea, and vomiting, may indicate a serious condition. Healthcare professionals should advise patients to consult a physician promptly under these circumstances. It is critical to note that the product should not be used for more than 2 days, and it is contraindicated for children under 3 years of age unless specifically directed by a healthcare provider.

General precautions must be observed to ensure safe use. Patients should not exceed the recommended dosage and should adhere strictly to the instruction of using the product for no longer than 2 days. Additionally, sharing this container among multiple users may facilitate the spread of infection, and therefore, it is advised that each individual use their own container.

Patients should be instructed to discontinue use and seek medical advice if sore throat symptoms do not improve within 7 days. They should also contact their healthcare provider if they experience persistent or worsening irritation, pain, or redness, or if they develop swelling, rash, or fever.

In the event of an overdose or accidental poisoning, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious adverse reactions include severe and persistent sore throat, particularly when accompanied by high fever, headache, nausea, and vomiting. Such symptoms may indicate a more serious condition, and patients are advised to consult a healthcare professional promptly.

It is important for patients to discontinue use and seek medical advice if sore throat symptoms do not improve within 7 days. Additionally, patients should stop use and consult a doctor or dentist if they experience any of the following: irritation, pain, or redness that persists or worsens; development of swelling, rash, or fever.

Patients should not use this medication for more than 2 days or administer it to children under 3 years of age unless directed by a healthcare provider.

Drug Interactions

There are currently no specific drug interactions identified for the medication. Additionally, no interactions with laboratory tests have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time. It is advisable for healthcare professionals to remain vigilant and consult updated resources as new data may emerge.

Packaging & NDC

Below are the non-prescription pack sizes of Phenol (sore throat spray). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 3 years of age should not use this product unless directed by a doctor. For children in this age group, consultation with a healthcare professional is advised prior to use.

Children under 12 years of age should be supervised during the use of this product to ensure safety and proper application.

For pediatric patients aged 3 years and older, the recommended dosage is one spray applied to the affected area every 2 hours, or as directed by a doctor or dentist.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy. Healthcare professionals should consider the potential risks and benefits when prescribing this medication to pregnant patients. Due to the lack of data, it is recommended that women of childbearing potential use effective contraception during treatment. If a patient becomes pregnant while taking this medication, healthcare providers should counsel her regarding the potential risks to the fetus and consider alternative treatment options.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement standard supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the substance involved. Additionally, healthcare professionals should consider contacting a poison control center for further guidance on management strategies tailored to the specific situation.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details have been reported in the available data.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. In the event of an overdose or accidental poisoning, patients should seek medical help or contact a Poison Control Center immediately.

Patients must be instructed not to exceed the recommended dose and to use the medication only as directed. It is important to inform patients that the medication should not be used for more than 2 days.

Healthcare providers should also caution patients that using this container by more than one person may lead to the spread of infection. Patients should be advised to stop using the medication and consult a doctor or dentist if sore throat symptoms do not improve within 7 days, or if irritation, pain, or redness persists or worsens, or if any swelling, rash, or fever develops.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity and efficacy.

Healthcare professionals are advised to inspect the product carefully before use. Specifically, the printed neck band should be intact; do not use the product if the neck band is broken or missing. Additionally, it is crucial to check the expiration date prior to administration to ensure the product is within its usable timeframe.

Additional Clinical Information

The medication is administered orally and should be taken every 2 hours or as directed by a healthcare professional. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Phenol, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)